Normolipidemia | Dyslipidemia | P value | ||
---|---|---|---|---|
Non-treatment | Treatment | |||
N (%) | 152 (12.3%) | 345 (28.1%) | 734 (59.6%) | < 0.0001 |
Sex | ||||
male | 92 (11.0%) | 246 (29.4%) | 500 (59.7%) | |
female | 60 (15.3%) | 99 (25.2%) | 234 (59.5%) | 0.0600 |
Age (years) | ||||
< 50 | 46 (12.5%) | 189 (51.4%) | 133 (36.1%) | |
50–60 | 57 (14.7%) | 90 (23.3%) | 240 (62.0%) | |
> 60 | 49 (10.3%) | 66 (13.9%) | 361 (75.8%) | < 0.0001 |
HbA1c (%) | ||||
< 7 | 49 (14.5%) | 82 (24.3%) | 207 (61.2%) | |
7–10 | 53 (9.2%) | 153 (26.5%) | 372 (64.4%) | |
> 10 | 50 (15.9%) | 110 (34.9%) | 155 (49.2%) | < 0.0001 |
T2DM duration (years) | ||||
< 3 | 33 (11.7%) | 125 (44.5%) | 123 (43.8%) | |
3–10 | 67 (13.8%) | 151 (31.1%) | 267 (55.1%) | |
> 10 | 52 (11.2%) | 69 (14.8%) | 344 (74.0%) | < 0.0001 |
BMI (kg/m2) | ||||
< 24 | 75 (20.5%) | 74 (20.3%) | 216 (59.2%) | |
≥ 24 | 77 (8.9%) | 271 (31.3%) | 518 (59.8%) | < 0.0001 |
Hypertension | ||||
Yes | 62 (10.7%) | 108 (18.7%) | 409 (70.6%) | |
No | 90 (13.8%) | 237 (36.3%) | 325 (49.8%) | < 0.0001 |
FLD | ||||
Yes | 20 (6.5%) | 97 (31.7%) | 189 (61.8%) | |
No | 132 (14.3%) | 248 (26.8%) | 545 (58.9%) | 0.0010 |